Global X S&P Biotech ETF (CURE) Stock Price, News & Analysis

Company Overview

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 2,243 shs
• Average Volume: N/A
• Market Capitalization: A$35.59 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CURE Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Global X S&P Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Global X S&P Biotech ETF investors own include W.P. Carey (WPC), Tesla (TSLA), Mondelez International (MDLZ) and DaVita (DVA).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: ASX:CURE
• CIK: N/A
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: A$35.59 million
• Optionable: Not Optionable
• Beta: N/A